Health, Pharma Sectors Will Be FTC Focus, Ohlhausen Says
In the midst of uncertainty about the direction antitrust and merger policy will take under the Trump administration, the acting head of the Federal Trade Commission said Friday it will prioritize...To view the full article, register now.
Already a subscriber? Click here to view full article